Mohlo by se vám také líbit

Více informací o knize Resistance to Proteasome Inhibitors in Cancer, 1

• Parametry knihy
• Anotace
• Oblíbené z jiného soudku

Nákupem získáte 509 bodů

Anotace knihy

The book explores cutting-edge strategies to overcome proteasome inhibitor resistance, including the second generation 20S proteasome inhibitors, novel combinational therapies, and new targets in the ubiquitin-proteasome pathway (e.g., ubiquitin E3 ligases, deubiquitinases, 19S proteasomal ATPases, histone deacetylases, oxidative stress and proteotoxic stress pathways and pharmacogenomic signature profiling) in resistant cancer cells. The mechanisms of action and resistance of proteasome inhibitors, such as bortezomib and carfilzomib in human cancers, including multiple myeloma, mantle cell lymphoma, acute leukemia, and solid tumors are explored in depth in this volume. §This timely volume unveils the most current discoveries of the mechanisms behind proteasome inhibitor resistance, which will help illuminate the future of cancer therapies.§

Parametry knihy

Zařazení knihy Knihy v angličtině Medicine Other branches of medicine Pharmacology

• Plný název: Resistance to Proteasome Inhibitors in Cancer, 1
• Podnázev: Molecular mechanisms and reversal strategies
• Autor: Q. Ping Dou
• Jazyk: Angličtina
• Vazba: Pevná
• Počet stran: 376
• EAN: 9783319067513
• ISBN: 3319067516
• ID: 02598126
• Nakladatelství: Springer, Berlin
• Hmotnost: 815 g
• Rozměry: 235 × 155 × 15 mm
• Rok vydání: 2014

Oblíbené z jiného soudku

---

---

---